← Leaderboards
Kevin G Shim
Mayo Clinic Rochester
$146,962
Attributed
$146,962
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$146,962 · 1
By mechanism
F30$146,962 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Evanthia Galanis$13,573,895
- Kah-Whye Peng$11,311,466
- Richard G Vile$15,977,609
- Autumn Schulze$1,152,872
- Shruthi Naik$1,310,428
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisEffective TherapyCytokineClinical TrialsAftercareDisorder ControlColorCytochrome C1Amino Acid SubstitutionClinical PracticeAutomobile DrivingBaseBraf GeneCancer VaccinesCareerCause Of DeathCellsCessation Of LifeCheckpoint TherapyChemotherapyClinicClinical DataClinically RelevantExcision
Grant awards (4)
Improving Efficacy and Safety of VSV Immunotherapy for Metastatic Melanoma$9,418
F30 · FY2019 · CA · contact PI
Improving Efficacy and Safety of VSV Immunotherapy for Metastatic Melanoma$49,524
F30 · FY2018 · CA · contact PI
Improving Efficacy and Safety of VSV Immunotherapy for Metastatic Melanoma$44,244
F30 · FY2017 · CA · contact PI
Improving Efficacy and Safety of VSV Immunotherapy for Metastatic Melanoma$43,776
F30 · FY2016 · CA · contact PI